• Replies 6 replies
  • Subscribers 2 subscribers
  • Views 116 views
  • Users 0 members are here
Related Content

Introducing the CMKC Advisory Board!

Kaitlin Baumer

We are thrilled to introduce the new Advisory Board for the CMKC! These accomplished professionals bring a wealth of expertise and passion to our work:

  1.    
  2.   
  3.   
  4.   
  5.   
  6.   

Stay tuned! In the upcoming weeks, you’ll hear firsthand why they’re excited about the potential of the CMKC, as well as learn more about their extensive professional experiences. And of course, if you have questions, don’t hesitate to share them below!

Parents

  • I’m honored to partner with the brilliant members of the CMKC Advisory Board and am pleased to collaborate with all of you in progressing this very important topic in our industry.  By fostering healthy knowledge sharing, expertise, meaningful solutions and reducing barriers to continuous manufacturing, we can improve quality supply to patients with reduced supply chain complexity and risk to product.  Together, we can be the catalyst to positive changes.

    My career spans 29 years in global pharma/biotech, including roles in Process Development, Manufacturing, Facility Start Ups, Regulatory, and Quality for large and small, clinical to commercial stage organizations, across multiple modalities and dosage forms.   I am greatly motivated by designing strategies and solutions that reduce complexity, improve safety and ultimately, provide reliable supply of life saving therapies to patients. 

    I am currently the SVP of Quality and CMC Regulatory at ReCode Therapeutics, enabling the development of mRNA lipid nanoparticles for rare diseases, and CEO of Clarity Global, LLC Consulting, delivering efficient strategies to organizations transitioning from clinical to commercial operations.  

    I look forward to engaging with all of you on this platform!

Reply

  • I’m honored to partner with the brilliant members of the CMKC Advisory Board and am pleased to collaborate with all of you in progressing this very important topic in our industry.  By fostering healthy knowledge sharing, expertise, meaningful solutions and reducing barriers to continuous manufacturing, we can improve quality supply to patients with reduced supply chain complexity and risk to product.  Together, we can be the catalyst to positive changes.

    My career spans 29 years in global pharma/biotech, including roles in Process Development, Manufacturing, Facility Start Ups, Regulatory, and Quality for large and small, clinical to commercial stage organizations, across multiple modalities and dosage forms.   I am greatly motivated by designing strategies and solutions that reduce complexity, improve safety and ultimately, provide reliable supply of life saving therapies to patients. 

    I am currently the SVP of Quality and CMC Regulatory at ReCode Therapeutics, enabling the development of mRNA lipid nanoparticles for rare diseases, and CEO of Clarity Global, LLC Consulting, delivering efficient strategies to organizations transitioning from clinical to commercial operations.  

    I look forward to engaging with all of you on this platform!

Children
No Data